These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 35387046

  • 21. Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.
    Klimek L, Novak N, Cabanillas B, Jutel M, Bousquet J, Akdis CA.
    Allergy; 2021 Nov; 76(11):3307-3313. PubMed ID: 33657648
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG, Burtecene N, Mustu U, Ocak S, Kasapcopur O, Kıykım A, Cokugras H.
    Allergol Immunopathol (Madr); 2023 Nov; 51(3):174-180. PubMed ID: 37169575
    [Abstract] [Full Text] [Related]

  • 23. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG, Gallenga CE, Caraffa A, Tetè G, Ronconi G, Conti P.
    J Biol Regul Homeost Agents; 2021 Nov; 35(3):839-842. PubMed ID: 34105336
    [Abstract] [Full Text] [Related]

  • 24. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
    Banerji A, Wickner PG, Saff R, Stone CA, Robinson LB, Long AA, Wolfson AR, Williams P, Khan DA, Phillips E, Blumenthal KG.
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478
    [Abstract] [Full Text] [Related]

  • 25. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic.
    Lyons D, Murray C, Hannigan S, Sui J, Alamin S, Conlon N, Keogan M, Khalib K, Fitzpatrick C, O'B Hourihane J, Carey M, Edgar JDM.
    Clin Exp Immunol; 2022 Aug 19; 209(2):182-187. PubMed ID: 35753019
    [Abstract] [Full Text] [Related]

  • 26. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.
    Hong A, Sardinas G.
    HCA Healthc J Med; 2022 Aug 19; 3(6):349-354. PubMed ID: 37427315
    [Abstract] [Full Text] [Related]

  • 27. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
    Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, Bernstein J, Bingemann T, Blumchen K, Byrne A, Bognanni A, Campbell D, Campbell R, Chagla Z, Chan ES, Chan J, Comberiati P, Dribin TE, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Grayson MH, Horner CC, Hourihane J, Katelaris CH, Kim H, Kelso JM, Lang D, Ledford D, Levin M, Lieberman J, Loh R, Mack D, Mazer B, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Oppenheimer J, Perrett KP, Ramsey A, Rank M, Robertson K, Sheikh J, Spergel JM, Stukus D, Tang MLK, Tracy JM, Turner PJ, Whalen-Browne A, Wallace D, Wang J, Waserman S, Witry JK, Worm M, Vander Leek TK, Golden DBK.
    J Allergy Clin Immunol Pract; 2021 Oct 19; 9(10):3546-3567. PubMed ID: 34153517
    [Abstract] [Full Text] [Related]

  • 28. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
    Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, Wood RA, Milner JD.
    J Allergy Clin Immunol; 2021 Jun 19; 147(6):2075-2082.e2. PubMed ID: 33857566
    [Abstract] [Full Text] [Related]

  • 29. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP, Desai AP, Loomis GJ.
    Vaccine; 2021 Jul 22; 39(32):4407-4409. PubMed ID: 34215453
    [Abstract] [Full Text] [Related]

  • 30. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    CDC COVID-19 Response Team, Food and Drug Administration.
    MMWR Morb Mortal Wkly Rep; 2021 Jan 15; 70(2):46-51. PubMed ID: 33444297
    [Abstract] [Full Text] [Related]

  • 31. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].
    Özden Ş, Tepetam FM, Atik Ö.
    Tuberk Toraks; 2023 Jun 15; 71(2):166-175. PubMed ID: 37345399
    [Abstract] [Full Text] [Related]

  • 32. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
    Erdeljic Turk V.
    Clin Immunol; 2021 Jun 15; 227():108748. PubMed ID: 33932618
    [Abstract] [Full Text] [Related]

  • 33. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy.
    Khokhar D, O'Shea KM, Akin C, Baldwin JL, Benjamin MR, Ravikumar R, Hosler M, McMorris MS, Sanders GM, Troost JP, Baptist AP, Oberdoerster DT, Kovalszki A.
    J Allergy Clin Immunol Glob; 2022 Nov 15; 1(4):209-216. PubMed ID: 36090592
    [Abstract] [Full Text] [Related]

  • 34. Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.
    Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, Wragg KM, Subbarao K, Nguyen THO, Rowntree LC, Allen LF, Bond K, Williamson DA, Truong NP, Plebanski M, Kedzierska K, Mahanty S, Chung AW, Caruso F, Wheatley AK, Juno JA, Kent SJ.
    ACS Nano; 2022 Aug 23; 16(8):11769-11780. PubMed ID: 35758934
    [Abstract] [Full Text] [Related]

  • 35. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
    Stehlin F, Mahdi-Aljedani R, Canton L, Monzambani-Banderet V, Miauton A, Girard C, Kammermann K, Meylan S, Ribi C, Harr T, Yerly D, Muller YD.
    Front Allergy; 2022 Aug 23; 3():818049. PubMed ID: 36238929
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination.
    Petrelli F, Giannini D, Pucci C, Del Corso I, Rocchi V, Dolcher MP, Pieve G, Pratesi F, Migliorini P, Puxeddu I.
    Int Arch Allergy Immunol; 2023 Aug 23; 184(1):54-62. PubMed ID: 36265449
    [Abstract] [Full Text] [Related]

  • 38. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
    Subasic CN, Butcher NJ, Minchin RF, Kaminskas LM.
    Mol Pharm; 2023 Jul 03; 20(7):3494-3504. PubMed ID: 37256791
    [Abstract] [Full Text] [Related]

  • 39. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.
    Barta BA, Radovits T, Dobos AB, Tibor Kozma G, Mészáros T, Berényi P, Facskó R, Fülöp T, Merkely B, Szebeni J.
    Vaccine X; 2024 Aug 03; 19():100497. PubMed ID: 38933697
    [Abstract] [Full Text] [Related]

  • 40. Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds.
    Ribak Y, Rubin L, Talmon A, Dranitzki Z, Shamriz O, Hershkowitz I, Tal Y, Hershko AY.
    Front Immunol; 2023 Aug 03; 14():1172896. PubMed ID: 37654487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.